Patents by Inventor Judith Soberman

Judith Soberman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF TRIPLE NEGATIVE BREAST CANCER
    Publication number: 20230255993
    Abstract: The present invention relates to compositions comprising at least one of pivarubicin and benzarubicin, or a pharmaceutically acceptable salt thereof, and methods for using the compositions in the treatment of triple negative breast cancer (TNBC) by administering an effective amount of the compositions to a subject. In some instances, the subject is a mammal, including at least one of human, feline, and canine mammals.
    Type: Application
    Filed: April 21, 2023
    Publication date: August 17, 2023
    Inventors: Leonard Lothstein, Judith Soberman, Tiffany N. Seagroves
  • Pivarubicin and benzarubicin compositions
    Patent number: 11666589
    Abstract: The present invention relates to compositions comprising at least one of pivarubicin and benzarubicin, or a pharmaceutically acceptable salt thereof, and methods for using the compositions in the treatment of triple negative breast cancer (TNBC) by administering an effective amount of the compositions to a subject. In some instances, the subject is a mammal, including at least one of human, feline, and canine mammals.
    Type: Grant
    Filed: March 2, 2021
    Date of Patent: June 6, 2023
    Inventors: Leonard Lothstein, Judith Soberman, Tiffany N. Seagroves
  • TREATMENT OF TRIPLE NEGATIVE BREAST CANCER
    Publication number: 20210268007
    Abstract: The present invention relates to compositions comprising at least one of pivarubicin and benzarubicin, or a pharmaceutically acceptable salt thereof, and methods for using the compositions in the treatment of triple negative breast cancer (TNBC) by administering an effective amount of the compositions to a subject. In some instances, the subject is a mammal, including at least one of human, feline, and canine mammals.
    Type: Application
    Filed: March 2, 2021
    Publication date: September 2, 2021
    Inventors: Leonard Lothstein, Judith Soberman, Tiffany N. Seagroves